BIO-Europe Digital 2021
Date: October 25–28, 2021
Location: Virtual Conference
SVP, Global Operations, Large Molecules, Catalent Biologics
Session Title: Leveraging European Biologics Expertise and Capacity to Combat the Pandemic
Session Date & Time: Available on demand beginning October 25, 2021
Abstract: As pharma companies and their global supply partners raced to support the development and scale-up of COVID vaccines and therapies, Catalent looked for opportunities to engage capacity across its biologics network. Because of recent investments in Europe, Catalent was able to leverage its European sites as a part of the solution. Join Mario Gargiulo, SVP Global Operations, Large Molecules, during this fireside chat, where he will discuss how Catalent relied on its sites in Italy and Belgium to support the development and manufacturing of COVID vaccines and therapies for Europe and the world.